Silverback Therapeutics Inc. (SBTX) Social Stream
SILVERBACK THERAPEUTICS INC (SBTX) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering SILVERBACK THERAPEUTICS INC.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
---|---|---|---|---|---|---|
2021-09-16 | 3 | $54 | $42 | $49.333 | $6.14 | 703.47% |
2021-11-11 | 3 | $52 | $32 | $42 | $6.14 | 584.04% |
2021-11-12 | 3 | $52 | $25 | $36.333 | $6.14 | 491.74% |
2022-04-01 | 3 | $6 | $1.8 | $3.9 | $6.14 | -36.48% |
2022-04-04 | 1 | $3.5 | $3.5 | $3.5 | $6.14 | -43% |
2022-05-13 | 4 | $5 | $1.8 | $3.433 | $6.14 | -44.09% |
Price Target Last Issued April 4, 2022
The Trend in the Analyst Price Target
SBTX's average price target has moved up $0.35 over the prior 42 days.
Over the past 26 weeks, SBTX's average upside potential has been 71.36%.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
---|---|---|---|---|---|---|
2021-11-12 | 3 | 52.0 | 25.0 | 36.333 | 8.45 | 329.98% |
2022-04-04 | 4 | 3.5 | 3.5 | 3.500 | 3.24 | 8.02% |
2022-04-04 | 1 | 6.0 | 1.8 | 3.766 | 3.24 | 16.23% |
2022-04-04 | 4 | 6.0 | 1.8 | 3.766 | 3.24 | 16.23% |
2022-05-13 | 3 | 5.0 | 1.8 | 3.433 | 2.96 | 15.98% |
SBTX Broker Recommendations Summary
Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
---|---|---|---|---|---|---|
3 | 0 | 0 | 3 | 0 | 0 | 3 |
The Trend in the Broker Recommendations
SBTX's average broker recommendation rating worsened by 1.4 over the prior 30 weeks.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- SILVERBACK THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 284.61% of all US stocks.
- SBTX has a higher average analyst price target than 285.65% of stocks in the small market cap category.
- SILVERBACK THERAPEUTICS INC's number of analysts covering the stock is greater than 123.12% of Healthcare stocks.
- In terms of how SILVERBACK THERAPEUTICS INC fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than -356.46% of that group.
Stocks similar to SILVERBACK THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are LABP, SNSE, and PHVS.
View All Top Stocks by Price Target
Is SBTX a Buy, Hold or Sell? See the POWR Ratings now!